Bharat Biotech International Limited (BBIL) has conveyed to the government that it has already submitted 90 per cent of documents to WHO for obtaining emergency use listing (EUL) for the Covaxin vaccine, sources said on Monday. The remaining documents are expected to be submitted by June,
AIIMS director Randeep Guleria on Monday said it is better to identify mucormycosis by its name rather than by the colour as labelling the same fungus with names of different colors can create confusion. Addressing a press conference by the Union health ministry, he clarified that
The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) and Panacea Biotec, one of the leading vaccine and pharmaceutical producers in India, today announced the launch of production of the Russian Sputnik V vaccine against coronavirus. The first batch produced at Panacea Biotec’s facilities at
Casirivimab and Imdevimab is indicated for restricted use in emergency situation for the treatment of mild to moderate COVID-19 in patients who are at high risk* of severe COVID-19 Roche India and Cipla Limited (BSE: 500087; NSE: CIPLA EQ, referred to as “Cipla”) today announced
The Pune district administration has directed health officials to screen COVID-19 survivors in rural areas to identify any suspected cases of mucormycosis, or black fungus. As per an order issued on Sunday by district Collector Rajesh Deshmukh, the health departments in rural areas have been instructed
Experts in Karnataka will study whether the rise in the Mucormycosis cases is linked to use of industrial oxygen and its possible contamination. Deputy Chief Minister C N Ashwath Narayan, who is also the head of the state’s COVID task force, held a meeting on Sunday
After black fungus, the Multi-system Inflammatory Syndrome in Children (MIS-C) is the next cause of concern for the medical fraternity to deal with the post COVID complications. The syndrome involving multi-organ is usually seen weeks after the peak of COVID wave and can pose a
Hyderabad based Yashoda Hospitals in their Somajigida unit will start Phase III Trials in association with Natco Pharma who received DCGI approval for conducting clinical trials for oral administration of Molnupiravir capsules for patients with mild and moderate COVID-19 symptoms. Announcing the commencement of the
American pharmaceutical company Pfizer and German company BioNTech pledged Friday to deliver 2 billion doses of their COVID-19 vaccine to middle- and low-income countries over the next 18 months, amid international calls for more vaccine solidarity. The companies, which together developed the first vaccine to
